Mesabi Trust Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Mesabi Trust hat ein Gesamteigenkapital von $22.1M und eine Gesamtverschuldung von $0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $26.2M bzw. $4.1M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$21.63m
Eigenkapital	US$22.12m
Gesamtverbindlichkeiten	US$4.13m
Gesamtvermögen	US$26.25m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Something To Consider Before Buying Mesabi Trust (NYSE:MSB) For The 4.1% Dividend

Apr 19

Mesabi Trust (NYSE:MSB) Has Rewarded Shareholders With An Exceptional 511% Total Return On Their Investment

Mar 01

Here's Why We're Wary Of Buying Mesabi Trust's (NYSE:MSB) For Its Upcoming Dividend

Jan 23

Should Mesabi Trust (NYSE:MSB) Be Part Of Your Income Portfolio?

Jan 18

Mesabi Trust declares $0.46 dividend

Jan 11

Mesabi Trust Remains Attractive To Yield-Centric Investors

Jan 05

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: MSBDie kurzfristigen Aktiva des Unternehmens ($26.2M) übersteigen seine kurzfristigen Passiva ($4.1M).

Langfristige Verbindlichkeiten: MSB hat keine langfristigen Verbindlichkeiten.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: MSB ist schuldenfrei.

Schulden abbauen: MSB hat in den letzten 5 Jahren keine Schulden gemacht.

Schuldendeckung: MSB hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: MSB hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.

Mesabi Trust Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Second quarter dividend of US$0.39 announced

Mesabi Trust Declares Distribution, Payable on November 20, 2024

Mesabi Trust: Cleveland-Cliffs Spat In Rear View For Now

Investor sentiment improves as stock rises 21%

Second quarter 2025 earnings released: EPS: US$0.41 (vs US$0.70 in 2Q 2024)

Upcoming dividend of US$0.30 per share

Mesabi Trust Declares Distribution, Payable on August 20, 2024

First quarter 2025 earnings released: EPS: US$0.27 (vs US$0.078 in 1Q 2024)

If Fed Doesn't Get Serious About Inflation, Buy Mesabi Trust (Rating Upgrade)

Full year 2024 earnings released: EPS: US$1.45 (vs US$0.41 in FY 2023)

Upcoming dividend of US$0.29 per share

Mesabi Trust Declares Distribution, Payable on May 20, 2024

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Mesabi Trust: Full Production Is Back Despite Cleveland-Cliffs' Ambitions

Upcoming dividend of US$0.37 per share at 6.8% yield

Mesabi Trust Declares Distribution, Payable on February 20, 2024

Third quarter 2024 earnings released: EPS: US$0.31 (vs US$0.032 loss in 3Q 2023)

Now 21% undervalued after recent price drop

Mesabi Trust: Unlikely Cleveland-Cliffs Shuts Northshore Down In The Near Term

Upcoming dividend of US$0.35 per share

Mesabi Trust Looks Attractive With Estimated Forward Yield Of 8.2% To 11.4%

Mesabi Trust Declares Distribution, Payable on November 20, 2023

Second quarter 2024 earnings released: EPS: US$0.70 (vs US$0.37 loss in 2Q 2023)

Mesabi Trust: There's A Strong Headwind, But Also An Opportunity

New major risk - Revenue and earnings growth

Full year 2023 earnings released: EPS: US$0.41 (vs US$5.24 in FY 2022)

Operating Issues And Recession Pricing Next: Avoid Mesabi Trust

Investor sentiment improves as stock rises 17%

Mesabi Trust Announces No Distribution for January 2023

Mesabi Trust says no dividend in January

Investor sentiment improved over the past week

Third quarter 2023 earnings released: US$0.032 loss per share (vs US$1.22 profit in 3Q 2022)

No independent directors

Investor sentiment deteriorated over the past week

Mesabi Trust: Short-Term This Doesn't Look Great, Long-Term I Like

Investor sentiment deteriorated over the past week

Mesabi Trust Determines No Distribution to Be Declared for October 2022 with Respect to Units of Beneficial Interest

Second quarter 2023 earnings released: US$0.37 loss per share (vs US$2.04 profit in 2Q 2022)

How Cleveland-Cliffs' CEO Pushed Mesabi Trust's Dividend Off A Cliff

Upcoming dividend of US$0.84 per share

Mesabi Trust dips dividend -19.2% to $0.84/share

First quarter 2023 earnings released: EPS: US$1.04 (vs US$0.65 in 1Q 2022)

Mesabi Trust Is Not So Easily Ousted

Full year 2022 earnings: EPS and revenues miss analyst expectations

No independent directors

Upcoming dividend of US$1.04 per share

Mesabi Trust Declares Distribution, Payable on May 20, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of US$1.75 per share

Mesabi Trust And Its Real Value

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Upcoming dividend of US$1.42 per share

Mesabi Trust (NYSE:MSB) Will Pay A Larger Dividend Than Last Year At US$1.42

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS US$2.04 (vs US$0.51 in 2Q 2021)

Upcoming dividend of US$0.09 per share

Mesabi Trust's (NYSE:MSB) Upcoming Dividend Will Be Larger Than Last Year's

First quarter 2022 earnings released: EPS US$0.65 (vs US$0.12 in 1Q 2021)

Full year 2021 earnings released: EPS US$1.78 (vs US$2.29 in FY 2020)

Upcoming dividend of US$0.89 per share

Something To Consider Before Buying Mesabi Trust (NYSE:MSB) For The 4.1% Dividend

New 90-day high: US$29.81

Mesabi Trust (NYSE:MSB) Has Rewarded Shareholders With An Exceptional 511% Total Return On Their Investment

Here's Why We're Wary Of Buying Mesabi Trust's (NYSE:MSB) For Its Upcoming Dividend

Upcoming Dividend of US$0.46 Per Share

Should Mesabi Trust (NYSE:MSB) Be Part Of Your Income Portfolio?

Mesabi Trust declares $0.46 dividend

Mesabi Trust Remains Attractive To Yield-Centric Investors

New 90-day high: US$29.00

Third quarter 2021 earnings released: EPS US$0.39